Premji Invest, an investment firm, led a $130m Series D round in BillionToOne, a next-generation molecular diagnostics company, with participation from Neuberger Berman,Adam Street Partners, Baillie Gifford, Hummingbird Ventures, Civilization Ventures, Libertus Capital, and Fifty Years.